Sonder Capital

Profile

Sonder Capital is a venture capital firm based in San Carlos, California, founded with a vision to transform healthcare through investment in medical devices, diagnostics, and healthtech. The firm was co-founded by Kate Garrett, Fred Moll, MD, along with partners including Jay Watkins and Deborah Kilpatrick, PhD. The team is composed of seasoned industry veterans with decades of experience in the medtech industry as founders, executives, and board members, which allows them to navigate challenges faced by entrepreneurs. They emphasize creating a new standard of care by actively engaging with the companies they invest in.

Sonder Capital focuses on early-stage investments in the medical device, diagnostic, and healthtech sectors with an emphasis on transformational innovation. They seek to back big ideas that have a significant impact on patient outcomes and aim for a $1B+ market cap. The firm invests across the US with a commitment to diversity, aiming to close the gap in venture-backed funding for female and minority-run businesses.

Notable investments by Sonder Capital include technologies aimed at significantly impacting patient care, although specific portfolio companies are not listed in the available sources. The firm's strategy includes actively partnering and advising entrepreneurs, supporting them from their companies' inception to potential acquisition or IPO.